U.S. markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.01+0.01 (+0.03%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
Operating Expense
125,665
125,665
106,215
1,225
Operating Income
-125,665
-125,665
-106,215
-1,225
Net Non Operating Interest Income Expense
-3,490
-3,490
-3,088
-13
Other Income Expense
87
87
-145,828
-50
Pretax Income
-129,068
-129,068
-255,131
-1,288
Net Income Common Stockholders
-129,068
-129,068
-255,131
-1,225
Diluted NI Available to Com Stockholders
-129,068
-129,068
-255,131
-1,225
Basic EPS
-
-
-22.45
-0.20
Diluted EPS
-
-
-22.45
-0.20
Basic Average Shares
-
-
11,367
6,098
Diluted Average Shares
-
-
11,367
6,098
Total Operating Income as Reported
-125,665
-125,665
-106,215
-1,225
Total Expenses
125,665
125,665
106,215
1,225
Net Income from Continuing & Discontinued Operation
-129,068
-129,068
-255,131
-1,288
Normalized Income
-129,163
-129,163
-158,859
-1,288
Interest Income
1,091
1,091
1,089
0
Interest Expense
4,581
4,581
4,177
13
Net Interest Income
-3,490
-3,490
-3,088
-13
EBIT
-124,487
-124,487
-250,954
-1,275
EBITDA
-124,164
-
-
-
Reconciled Depreciation
323
323
8
-
Net Income from Continuing Operation Net Minority Interest
-129,068
-129,068
-255,131
-1,288
Total Unusual Items Excluding Goodwill
95
95
-96,272
0
Total Unusual Items
95
95
-96,272
0
Normalized EBITDA
-124,259
-124,259
-154,674
-1,275
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0